What is the pipeline for future medications for obesity?

Obesity is a chronic disease associated with increased risk of obesity-related complications and mortality. Our better understanding of the weight regulation mechanisms and the role of gut-brain axis on appetite has led to the development of safe and effective entero-pancreatic hormone-based treatme...

Celý popis

Podrobná bibliografia

Vydané v:	International journal of obesity (2005) Ročník 49; číslo 3; s. 433
Hlavní autori:	Melson, Eka, Ashraf, Uzma, Papamargaritis, Dimitris, Davies, Melanie J
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England 01.03.2025
Predmet:	Anti-Obesity Agents - therapeutic use Glucagon-Like Peptide 1 Glucagon-Like Peptide-1 Receptor Agonists Glucagon-Like Peptides - therapeutic use Humans Obesity - drug therapy
ISSN:	1476-5497, 1476-5497
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!